Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Zinzino AB (publ) (ZZ-B.ST)
Gothenburg, SE
Operating as a direct sales enterprise, Zinzino AB (publ) markets and distributes a comprehensive selection of nutritional supplements, coffee products, coffee machines, and associated accessories. The company's diverse offerings encompass health-focused supplements for equilibrium, immune support, weight control, and dermatological care. Furthermore, it supplies a range of espresso apparatus, various coffees, specialty teas, and other related accoutrements. Zinzino maintains a widespread international footprint, serving markets in numerous countries including Sweden, Norway, Denmark, Finland, Iceland, Estonia, Lithuania, Latvia, Germany, Austria, Switzerland, the Netherlands, Poland, Hungary, Romania, Spain, Cyprus, France, Greece, Italy, the United Kingdom, Czech Republic, Slovakia, the United States, Canada, Singapore, Malaysia, Taiwan, Thailand, Hong Kong, Australia, South Africa, and India. Established in 2005, Zinzino AB (publ) is headquartered in Gothenburg, Sweden, with additional operational bases situated in Finland, Latvia, Norway, the USA, Australia, Hong Kong, Malaysia, and India.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +7.09% | +13.66% | +14.81% | +16.43% | -11.95% | -5.31% | -22.86% | +242.82% | +92.34% | +849.36% | +9,773.33% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Household & Personal Products: +3.3%+43.8% ★ Q1'26: +27.4% (vs Q1'25)
-
EPS growth Household & Personal Products: +8.8%+89.1% ★ Q1'26: +81.2% (vs Q1'25)
-
FCF margin FCF growth · Household & Personal Products: +44.8%+9.4% Q1'26: +13.4% (vs Q1'25)
-
EBIT margin Household & Personal Products: +9.9%+7.7% Q1'26: +14.2% (vs Q1'25)
-
ROIC Household & Personal Products: +8.2%— Q1'26: +121.2% (vs Q1'25)
-
Share dilution Household & Personal Products: +0.2%+1.8% Q1'26: +2.7% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Household & Personal Products: -0.51×0.15× ★ Q1'26: 0.12× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 1 Rev. Ana. 1 EPS Ana. |
Dec 2027 1 Rev. Ana. 1 EPS Ana. |
Dec 2028 1 Rev. Ana. 1 EPS Ana. |
Dec 2029 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|
| Revenue |
1.36B
est: 1.49B (-9.0%)
|
1.76B
est: 1.77B (-0.2%)
|
2.21B
est: 2.09B (+5.6%)
|
3.17B
est: 3.34B (-5.2%)
|
4.01B
4.01B – 4.01B
+19.8% YoY
|
4.51B
4.51B – 4.51B
+12.4% YoY
|
4.85B
4.85B – 4.85B
+7.7% YoY
|
5.16B
5.16B – 5.16B
+6.3% YoY
|
| EBITDA |
117.02M
est: 163.54M (-28.4%)
|
245.88M
est: 194.09M (+26.7%)
|
253.59M
est: 223.67M (+13.4%)
|
278.10M
est: 358.10M (-22.3%)
|
429.14M
429.14M – 429.14M
+19.8% YoY
|
482.47M
482.47M – 482.47M
+12.4% YoY
|
519.62M
519.62M – 519.62M
+7.7% YoY
|
552.28M
552.28M – 552.28M
+6.3% YoY
|
| EBIT |
91.95M
est: 137.42M (-33.1%)
|
213.89M
est: 163.08M (+31.2%)
|
222.81M
est: 191.19M (+16.5%)
|
244.77M
est: 306.10M (-20.0%)
|
366.83M
366.83M – 366.83M
+19.8% YoY
|
412.41M
412.41M – 412.41M
+12.4% YoY
|
444.17M
444.17M – 444.17M
+7.7% YoY
|
472.08M
472.08M – 472.08M
+6.3% YoY
|
| Net Income |
67.70M
est: 91.46M (-26.0%)
|
163.74M
est: 183.30M (-10.7%)
|
169.17M
est: 196.28M (-13.8%)
|
324.32M
est: 294.99M (+9.9%)
|
359.91M
359.91M – 359.91M
+22.0% YoY
|
407.20M
407.20M – 407.20M
+13.1% YoY
|
440.98M
440.98M – 440.98M
+8.3% YoY
|
471.00M
471.00M – 471.00M
+6.8% YoY
|
| SGA |
196.96M
est: 198.39M (-0.7%)
|
252.25M
est: 235.45M (+7.1%)
|
291.73M
est: 225.68M (+29.3%)
|
—
est: 361.32M (-100.0%)
|
433.00M
433.00M – 433.00M
+19.8% YoY
|
486.80M
486.80M – 486.80M
+12.4% YoY
|
524.28M
524.28M – 524.28M
+7.7% YoY
|
557.23M
557.23M – 557.23M
+6.3% YoY
|
| EPS |
2.01
est: 2.48 (-19.0%)
|
4.83
est: 4.97 (-2.8%)
|
4.93
est: 5.23 (-5.7%)
|
9.09
est: 7.86 (+15.6%)
|
9.59
9.59 – 9.59
+22.0% YoY
|
10.85
10.85 – 10.85
+13.1% YoY
|
11.75
11.75 – 11.75
+8.3% YoY
|
12.55
12.55 – 12.55
+6.8% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-22 | A | 4/5 | 5/5 | 5/5 | 5/5 | 3/5 | 3/5 | 1/5 |
| 2026-05-21 | A | 4/5 | 5/5 | 5/5 | 5/5 | 3/5 | 3/5 | 1/5 |
| 2026-05-20 | A | 4/5 | 5/5 | 5/5 | 5/5 | 3/5 | 3/5 | 1/5 |
| 2026-05-19 | A | 4/5 | 5/5 | 5/5 | 5/5 | 3/5 | 3/5 | 1/5 |
| 2026-05-18 | A | 4/5 | 5/5 | 5/5 | 5/5 | 3/5 | 3/5 | 1/5 |
| 2026-05-15 | A | 4/5 | 5/5 | 5/5 | 5/5 | 3/5 | 3/5 | 1/5 |
| 2026-05-13 | A | 4/5 | 5/5 | 5/5 | 5/5 | 3/5 | 3/5 | 1/5 |
| 2026-05-12 | A | 4/5 | 5/5 | 5/5 | 5/5 | 3/5 | 3/5 | 1/5 |
| 2026-05-11 | A | 4/5 | 5/5 | 5/5 | 5/5 | 3/5 | 3/5 | 1/5 |
| 2026-05-08 | A | 4/5 | 5/5 | 5/5 | 5/5 | 3/5 | 3/5 | 1/5 |
| 2026-05-07 | A | 4/5 | 5/5 | 5/5 | 5/5 | 3/5 | 3/5 | 1/5 |
| 2026-05-06 | A | 4/5 | 5/5 | 5/5 | 5/5 | 3/5 | 3/5 | 1/5 |
| 2026-05-05 | A | 4/5 | 5/5 | 5/5 | 5/5 | 3/5 | 3/5 | 1/5 |
| 2026-05-04 | A | 4/5 | 5/5 | 5/5 | 5/5 | 3/5 | 3/5 | 1/5 |
| 2026-04-30 | A | 4/5 | 5/5 | 5/5 | 5/5 | 3/5 | 3/5 | 1/5 |
| 2026-04-29 | A | 4/5 | 5/5 | 5/5 | 5/5 | 3/5 | 3/5 | 1/5 |
| 2026-04-28 | A | 4/5 | 5/5 | 5/5 | 5/5 | 3/5 | 3/5 | 1/5 |
| 2026-04-27 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 3/5 | 1/5 |
| 2026-04-24 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 3/5 | 1/5 |
| 2026-04-23 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 3/5 | 1/5 |
| 2026-04-22 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 3/5 | 1/5 |
| 2026-04-21 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 3/5 | 1/5 |
| 2026-04-20 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 3/5 | 1/5 |
| 2026-04-17 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 3/5 | 1/5 |
| 2026-04-16 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 3/5 | 1/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | iShares International Small-Cap Equity Factor ETF ISCF | 0.04% | 234.4K | 0.24% |
| 2 | Avantis International Small Cap Value ETF AVDV | 0.03% | 5.42M | 0.36% |
| 3 | Avantis Global Small Cap Value UCITS ETF AVGS.L | 0.02% | 177.8K | 0.39% |
| 4 | Avantis International Small Cap Equity ETF AVDS | 0.01% | 47.3K | 0.30% |
| 5 | Avantis Responsible International Equity ETF AVSD | 0.00% | 19.4K | 0.23% |
| 6 | Avantis International Equity ETF AVDE | 0.00% | 361.0K | 0.23% |
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Dag Bergheim Pettersen | Chief Executive Officer | 13M | male |
| Gabriele Helmer | Chief Marketing Officer | 43.0K | female |
| Daniel Vennerstrand | Chief Technical Officer | — | male |
| Fredrik Nielsen | Chief Financial Officer & Head of Investor Relations | — | male |
| Fredrik Skarnaes Hansen | Managing Director of Faun Pharma | — | male |
| Greta Billing | Chief Development Officer | — | female |
| Henrik Hammargren | Chief Supply Chain Officer | — | male |
| Jakob Spijker | President of Sales of New Europe & Africa | — | male |
| Katriin Laneep | Chief Support Officer | — | female |
| Linda Johnsson | Chief Human Resources Officer | — | — |
| Maya Koster | Vice President of France | — | female |
| Michael Perry | Chief Operating Officer of USA | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for ZZ-B.ST
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
